EMMI, GIACOMO
 Distribuzione geografica
Continente #
AS - Asia 7.543
NA - Nord America 5.756
EU - Europa 3.479
SA - Sud America 1.921
AF - Africa 274
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.005
Nazione #
US - Stati Uniti d'America 5.371
SG - Singapore 2.186
IT - Italia 1.607
BR - Brasile 1.456
CN - Cina 1.242
VN - Vietnam 1.043
BD - Bangladesh 826
HK - Hong Kong 687
KR - Corea 660
FR - Francia 303
NL - Olanda 211
DE - Germania 206
GB - Regno Unito 174
PL - Polonia 172
AR - Argentina 164
RU - Federazione Russa 164
TR - Turchia 153
IN - India 151
CA - Canada 142
FI - Finlandia 142
MX - Messico 140
SE - Svezia 130
JP - Giappone 119
ES - Italia 92
ID - Indonesia 79
EC - Ecuador 75
CO - Colombia 73
ZA - Sudafrica 72
MA - Marocco 68
IQ - Iraq 52
AT - Austria 46
SA - Arabia Saudita 44
PE - Perù 43
PK - Pakistan 42
CL - Cile 40
EG - Egitto 34
BE - Belgio 32
UA - Ucraina 30
DZ - Algeria 28
PY - Paraguay 27
CH - Svizzera 26
IL - Israele 26
UZ - Uzbekistan 25
IE - Irlanda 22
TH - Thailandia 22
VE - Venezuela 22
BG - Bulgaria 21
CR - Costa Rica 20
TN - Tunisia 20
PH - Filippine 19
JM - Giamaica 17
AU - Australia 16
CZ - Repubblica Ceca 16
IR - Iran 16
KE - Kenya 16
PT - Portogallo 15
JO - Giordania 14
AZ - Azerbaigian 13
BY - Bielorussia 13
LT - Lituania 13
MY - Malesia 13
NP - Nepal 12
TW - Taiwan 12
UY - Uruguay 12
DO - Repubblica Dominicana 10
AE - Emirati Arabi Uniti 9
KZ - Kazakistan 9
TT - Trinidad e Tobago 9
CY - Cipro 8
GT - Guatemala 8
HN - Honduras 8
LB - Libano 8
GR - Grecia 7
AO - Angola 6
BO - Bolivia 6
KG - Kirghizistan 6
OM - Oman 6
PA - Panama 6
PS - Palestinian Territory 6
SY - Repubblica araba siriana 6
ET - Etiopia 5
GE - Georgia 5
LV - Lettonia 5
NI - Nicaragua 5
PR - Porto Rico 5
RO - Romania 5
SN - Senegal 5
LK - Sri Lanka 4
MD - Moldavia 4
MP - Marianne Settentrionali, isole 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
XK - ???statistics.table.value.countryCode.XK??? 4
BS - Bahamas 3
BW - Botswana 3
CU - Cuba 3
GY - Guiana 3
HR - Croazia 3
HU - Ungheria 3
KH - Cambogia 3
Totale 18.945
Città #
Singapore 1.090
Ashburn 932
San Jose 686
Hong Kong 671
Seoul 654
Hefei 528
Ho Chi Minh City 373
Boardman 265
Trieste 253
Milan 252
Los Angeles 226
Hanoi 223
Chicago 203
Fairfield 193
Beijing 175
New York 167
Houston 129
Lauterbourg 126
São Paulo 116
Helsinki 114
Santa Clara 112
Zgierz 112
Seattle 102
Chandler 99
Woodbridge 98
Council Bluffs 96
Buffalo 88
Dallas 88
Wilmington 88
Rome 85
Cambridge 68
Ann Arbor 62
London 61
Mexico City 60
Frankfurt am Main 59
Miano 57
Da Nang 51
Tokyo 51
Moscow 50
Rio de Janeiro 47
Naples 46
Haiphong 44
Istanbul 42
Redondo Beach 42
Belo Horizonte 38
Casablanca 38
Toronto 37
Ankara 35
Salt Lake City 35
Warsaw 35
Lima 32
Munich 30
Guangzhou 27
Guayaquil 27
Nuremberg 27
Atlanta 26
Florence 26
Johannesburg 26
Turin 26
Biên Hòa 25
Orem 24
Princeton 24
Vienna 24
Curitiba 23
Montreal 23
Shanghai 23
Tashkent 23
Boston 22
Brasília 22
Brooklyn 22
Brussels 22
Porto Alegre 22
Salvador 22
Thái Bình 22
Amsterdam 21
Bogotá 21
Bologna 21
Columbus 21
Denver 21
Dublin 21
Campinas 20
Jacksonville 20
Paris 20
Quito 20
Verona 20
Cairo 19
Charlotte 19
Dhaka 19
Genoa 19
Madrid 19
Manchester 19
Sofia 19
Tampa 19
The Dalles 19
Buenos Aires 18
Cape Town 18
Düsseldorf 18
Goiânia 18
Riyadh 18
Santiago 18
Totale 10.397
Nome #
Vascular Behçet syndrome: from pathogenesis to treatment 677
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 353
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 327
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 321
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 311
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 305
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 300
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 299
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 281
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 274
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 266
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study 224
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 212
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 203
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 201
Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach 186
Behçet's syndrome 183
PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis 167
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies 166
Infliximab and Cogan's syndrome 152
Presentation and progression of MPO-ANCA interstitial lung disease 145
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 141
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 130
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 129
Therapeutic approach to central nervous system involvement of Behçet's disease 127
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis 124
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 123
Advancing Thrombosis Research: A Novel Device for Measuring Clot Permeability 120
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 119
Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort 118
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors 116
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 116
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 115
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 110
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 110
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis 107
Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 104
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 104
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 101
Significance of PR3-ANCA Positivity in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) 100
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 99
Serum IgG2 antibody multi-composition in Systemic Lupus Erythematosus and in Lupus nephritis (Part 2). Prospective study 99
A TNFSF13B Functional Variant Is Not Involved in Systemic Sclerosis and Giant Cell Arteritis Susceptibility 99
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 98
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 96
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases 95
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 93
A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome 93
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 92
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 91
Biologics for eosinophilic granulomatosis with polyangiitis 90
Evidence of subclinical atherosclerosis in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 90
135. ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS 88
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 87
Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology 86
At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement 86
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries 85
Development and implementation of the AIDA International Registry for patients with Behçet's disease 85
A multicenter approach to evaluate omalizumab effectiveness in Samter's triad 84
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry 83
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 83
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 83
A biochemical approach to detect oxidative stress in infertile women undergoing assisted reproductive technology procedures 83
A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon 82
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry 82
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 81
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome 81
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome 81
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 80
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 80
Epidemiology of SLE in Italy: An observational study using a primary care database 80
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 79
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study 79
Sjögren’s syndrome: a systemic autoimmune disease 78
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 78
Pharmacological interventions for the prevention of fetal growth restriction: a systematic review and network meta-analysis 78
298. RITUXIMAB FOR DIFFICULT-TO-TREAT CHRONIC PARIAORTITIS: A CASE-SERIES OF 20 PATIENTS 78
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry 77
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children 76
Circulating miRNome profiling data in Behçet's syndrome 76
Effectiveness and safety of intravenous immunoglobulin for peripheral neuropathy in EGPA patients: a retrospective study 75
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 75
Occupational Exposures and Smoking in Eosinophilic Granulomatosis With Polyangiitis: A Case–Control Study 75
The Sound of Interconnectivity; The European Vasculitis Society 2022 Report 75
Blood Leukocyte ROS Production Reflects Seminal Fluid Oxidative Stress and Spermatozoa Dysfunction in Idiopathic Infertile Men 74
Eosinophilic granulomatosis with polyangiitis-related myocarditis during mepolizumab therapy reveals a Th1/Th17-mediated vasculitic response 73
Pathogenesis of Behçet's Syndrome: Genetic, Environmental and Immunological Factors 73
Behçet's syndrome patients exhibit specific microbiome signature 72
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 72
Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature 72
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 71
Prevalence and clinical course of SARS-CoV-2 infection in patients with Behçet's syndrome 71
Core Set of Domains for Outcome Measures in Behçet Syndrome 71
Neutrophil-mediated mechanisms of damage and in vitro protective effect of colchicine in non-vascular Behçet's syndrome 71
Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation 71
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 71
The impact of environmental factors on aetiopathogenesis and clinical manifestations of Behçet's syndrome 71
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology 70
An insight into giant cell arteritis pathogenesis: Evidence for oxidative stress and sirt1 downregulation 70
Neutrophil Extracellular Traps in the Autoimmunity Context 70
Totale 12.624
Categoria #
all - tutte 53.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022213 28 10 3 22 5 19 9 2 22 24 14 55
2022/2023294 24 55 17 43 28 46 4 16 38 5 11 7
2023/2024446 15 18 16 14 27 24 41 35 3 188 38 27
2024/20253.169 35 67 114 80 451 454 303 161 142 342 276 744
2025/202614.516 1.104 1.153 1.325 1.805 665 853 1.177 553 1.353 1.783 1.251 1.494
2026/202723 23 0 0 0 0 0 0 0 0 0 0 0
Totale 19.710